112284 ⎘
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
Sub-classes:STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS
#2ERYTHRITOL-INDUCIBLE PROMOTER, AND TARGET SUBSTANCE PRODUCTION METHOD USING SAME
#3GENE ACTIVATION AND INTERFERENCE TARGETS FOR EXHAUSTION/DYSFUNCTIONRESISTANT T CELL PRODUCTS AND USES THEREOF
#4GENE THERAPY VECTORS FOR TREATMENT OF CANCER
#5NOVEL RECEPTORS FOR TRANSCRIPTION REGULATION
#6A NEW INDUCER FOR METHANOL-FREE PICHIA PASTORIS EXPRESSION SYSTEM
#7COMPOSITIONS AND METHODS FOR CHIMERIC LIGAND RECEPTOR (CLR)-MEDIATED CONDITIONAL GENE EXPRESSION
#8COMPOSITIONS AND METHODS FOR CHIMERIC LIGAND RECEPTOR (CLR)-MEDIATED CONDITIONAL GENE EXPRESSION
#9INDUCTION OF MEIOTIC RECOMBINATION USING A CRISPR SYSTEM
#10Hepatocyte Based Insulin Gene Therapy for Diabetes
#11GLUCOSYLTRANSFERASE CATALYZING REBAUDIOSIDE A TO PRODUCE REBAUDIOSIDE M AND USE THEREOF
#12CONTROL SYSTEM FOR INDUCING TRANSGENE EXPRESSION BY MEANS OF D-2-HG, AND CONSTRUCTION METHOD THEREFOR AND USES THEREOF
#13Low Dose Psilocybin in Foodstuff and Microbes for Same
#14PSEUDOMONAS RECOMBINANT PROTEIN EXPRESSION SYSTEM
#15ZIKV-BASED GENE DELIVERY SYSTEM
#16SYSTEMS, METHODS, AND COMPOSITIONS FOR AN INDUCIBLE PROMOTER SYSTEM
#17OPTIMIZED CLN1 GENES AND EXPRESSION CASSETTES AND THEIR USE
#18SPLIT RIBOZYME BIOSENSOR SYSTEMS
#19A LOOPABLE TRANSLATOR FOR THE SYNTHESIS OF REPETITIVE PROTEINS
#20RECOMBINANT EXPRESSION VECTOR FOR SECRETION OF INTERLEUKIN-21, AND ATTENUATED SALMONELLA STRAIN TRANSFORMED BY MEANS OF SAME
#21GENETIC CIRCUITS
#22Electromagnetic Field-Responsive Gene Promoter and Use Thereof
#23TARGETED INTEGRATION OF NUCLEIC ACIDS
#24Conjugates of Guide RNA-Cas Protein Complex
#25VECTOR
#26FUSOGENIC LIPID NANOPARTICLES AND METHODS FOR THE MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE
#27Tightly-Regulated Inducible Expression System for Production of Biologics Using Stable Cell Lines
#28INDUCIBLE PROMOTER, VECTOR AND HOST CELL BASED THEREON
#29COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION
#30SEQUENCE FOR PROTEIN DECAY
#31INDUCIBLE PROMOTER FOR GENE EXPRESSION CONTROL
#32A SYSTEM FOR DRUG-INDUCIBLE EXPRESSION OF A POLYNUCLEOTIDE
#33CHEMOGENETIC REGULATION OF PEPTIDE FUNCTION
#34MULTIPARTITE RECEPTOR AND SIGNALING COMPLEXES
#35METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#36NOVEL REGULATOR VIPR IN BACILLUS STRAINS
#37REDUCTION OF IRON LEVELS BY IRON RESPONSIVE PROTEIN SEQUESTRATION WITH SHORT RNAS
#38METHODS AND COMPOSITIONS FOR PRODUCING OOGONIA-LIKE CELLS
#39COMBINED GENE AND RADIO THERAPY FOR THE TREATMENT OF CANCER
#40EXPRESSION SYSTEM FOR THE TREATMENT OF CANCER
#41VIRAL VECTORS ENCODING GLP-2 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING SHORT BOWEL SYNDROME
#42VIRAL VECTORS ENCODING PARATHYROID HORMONE FUSIONS AND USES THEREOF IN TREATING HYPOPARATHYROIDISM
#43METHODS AND COMPOSITIONS FOR CONTROLLING T CELL ACTIVATION
#44Synthetic Chromosome Encoding Two Or More Chimeric Antigen Receptors Binding To Tumor Associated Antigens
#45PRODUCTION OF PSYCHEDELIC COMPOUNDS
#46METHODS AND SYSTEMS FOR DIFFERENTIATION OF CELLS USING OPTOGENETICS
#47AAV VECTORS FOR DELIVERY OF GLP-1 RECEPTOR AGONIST FUSIONS
#48METHODS OF USE, SYSTEMS, AND BIOSENSING MICROBES
#49COMPOSITIONS AND METHODS FOR ENGINEERING STABLE TREGS
#50Stable Cell Lines for Inducible Production of rAAV Virions
#51MODIFIED BACTERIUM WITH ANTI-TUMOUR ACTIVITY
#52MOLECULAR RECORDING METHODS AND SYSTEMS TO CAPTURE LINEAGE RELATIONSHIPS IN DIFFERENTIATING STEM CELLS
#53PRODUCTION OF GENE THERAPY VECTOR IN ENGINEERED BACTERIA
#54KNOCKOUT OF ptsP GENE ELEVATES ACTIVE GENE EXPRESSION
#55INDUCTION OF NEURAL PROGENITOR CELLS, OLIGODENDROCYTE PROGENITOR CELLS, AND OLIGODENDROCYTES BY STEM CELL DIFFERENTIATION USING LANDMARK TRANSCRIPTION FACTORS
#56SELF-REPLICATING RNA AND USES THEREOF
#57EXPRESSION SYSTEM FOR CONSTITUTIVE OR CUMATE-INDUCIBLE EXPRESSION IN CHO CELLS
#58SMALL MOLECULE-REGULATED GENE EXPRESSION SYSTEM
#59BIOSENSORS FOR DETECTING AND/OR NEUTRALIZING BIOAVAILABLE URANIUM AND RELATED U-SENSITIVE GENETIC MOLECULAR COMPONENTS, GENE CASSETTES, VECTORS, GENETIC CIRCUITS, COMPOSITIONS, METHODS AND SYSTEMS
#60Genetically Engineered Eukaryotic Cells and Cell Lines and Uses Thereof
#61PRODUCTION AND SEPARATION OF 3-HYDROXYPROPIONIC ACID
#62RECOMBINANT EXPRESSION VECTOR FOR HIGH EXPRESSION OF BRAZZEIN IN SACCHAROMYCES CEREVISIAE AND METHOD FOR MASS-PRODUCTION OF BRAZZEIN USING THE SAME
#63Hypoxia-Triggered Artificial Transcription Factor, a Hypoxia-Triggered Transcription Control System and Use Thereof
#64Programmable Nanoencapsulation for Delivery of Probiotics in Vivo
#65METHODS AND COMPOSITIONS FOR REMOTE CONTROL OF T CELL THERAPIES BY THERMAL TARGETING
#66METHODS FOR GENERATING MECHANICALLY-RESPONSIVE CELLS AND USES THEREOF
#67TRANSCRIPTION FACTOR
#68SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES
#69SYSTEMS AND METHODS FOR HIGH YIELDING RECOMBINANT MICROORGANISMS AND USES THEREOF
#70Self-replicating RNA and uses thereof
#71INSULIN GENE THERAPY TO TREAT DIABETES
#72DRUG-REGULATABLE TRANSCRIPTION FACTORS
#73PRODUCTION OF VACCINIA CAPPING ENZYME
#74CONFERRING DROUGHT TOLERANCE AND BIOMASS ACCUMULATION THROUGH THE PLANT-SPECIFIC RFS GENE FAMILY
#75RADIO FREQUENCY RESPONSIVE PLANT EXPRESSION VECTOR
#76ERT2 MUTANTS AND USES THEREOF
#77CONTROLLED EXPRESSION OF VIRAL PROTEINS
#78SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES
#79Low Dose Psilocybin in Foodstuff and Microbes for Same
#80INTRACELLULAR DELIVERY OF THERAPEUTIC PROTEINS DESIGNED TO INVADE AND AUTONOMOUSLY LYSE AND METHODS OF USE THEREOF
#81A TRANS-COMPLEMENTATION SYSTEM FOR SARS-COV-2
#82BACTERIAL CONTINUOUS EVOLUTION SYSTEM, ORTHOGONAL ERROR-PRONE DNA POLYMERASE, AND CONTINUOUS EVOLUTION METHOD
#83DE NOVO ENGINEERING OF A BACTERIAL LIFESTYLE PROGRAM
#84MINIMAL BILE ACID INDUCIBLE PROMOTERS FOR GENE THERAPY
#85MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST
#86METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING
#87LIGHT-CONTROLLED VIRAL TRANSDUCTION
#88CARBON-SOURCE REGULATED PROTEIN PRODUCTION IN A RECOMBINANT HOST CELL
#89VIRAL VECTOR-PRODUCING CELLS HAVING IMPROVED ABILITY TO PRODUCE VECTOR, METHOD FOR PRODUCING SAME AND METHOD FOR SELECTING SAME
#90FRATAXIN EXPRESSION CONSTRUCTS
#91INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION
#92INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION
#93METHODS OF TREATING GLIOBLASTOMA
#94FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS
#95Optimized CLN1 genes and expression cassettes and their use
#96HSV VECTORS WITH ENHANCED REPLICATION IN CANCER CELLS
#97Methods and compositions for transducing lymphocytes and regulating the activity thereof
#98FORMATE-INDUCIBLE PROMOTERS AND METHODS OF USE THEREOF
#99DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF
#100CONTROLLED TRANSCRIPTION OF POLYNUCLEOTIDES
#101CELL LINES FOR RECOMBINANT AAV PRODUCTION AND AAV-IMPLEMENTED PROTEIN PRODUCTION
#102Replication-competent controlled alpha-herpesvirus vectors and uses therefore
#103Aptamers That Bind Thiamine Analogs and Derivatives
#104SYSTEMS AND METHOD FOR THE PRODUCTION OF GRIFFITHISIN AND RELATED PROTEINS
#105Inducible CRISPR system expression and applications thereof
#106METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#107DUAL PROMOTER SYSTEMS
#108LIGHT-INDUCIBLE GENE ACTIVATION SYSTEMS AND METHODS FOR MAKING AND USING THEM
#109RAPID REMOVAL OF A SELF-REPLICATING FUNGAL PLASMID FOR EFFICIENT MARKER CYCLING
#110APPLYING OPTOGENETIC AMPLIFIER CIRCUITS FOR MULTI-PHASE LIGHT CONTROLLED MICROBIAL FERMENTATIONS
#111GENE EXPRESSION SYSTEM FOR RAPID CONSTRUCTION OF MULTIPLE-GENE PATHWAY IN OLEAGINOUS YEASTS
#112SYSTEMS AND METHODS FOR HIGH YIELDING RECOMBINANT MICROORGANISMS AND USES THEREOF
#113FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS
#114AUTOINDUCER-2 (AI-2) MOLECULAR RESPONSE-BASED STARTING ELEMENT AND ESCHERICHIA COLI (E. COLI) DYNAMIC REGULATION SYSTEM AND METHOD CONSTRUCTED THEREBY
#115ACTIVITY-DEPENDENT GENE THERAPY FOR NEUROLOGICAL DISORDERS
#116SELECTABLE MARKER PROTEINS, EXPRESSION VECTORS, ENGINEERED CELLS AND EXTRACELLULAR VESICLES FOR THE PRODUCTION OF VIRUS-LIKE PARTICLES FOR THERAPEUTIC AND PROPHYLACTIC APPLICATIONS
#117Production and separation of 3-hydroxypropionic acid
#118GPC3 CAR- T CELLS SECRETING IL-18 AND METHODS OF MAKING AND USING THE SAME
#119EXOSOMAL NUCLEIC ACID VACCINE MODULARLY CONFIGURED TO HARNESS MULTIPLE ANTIGEN PRESENTATION MECHANISMS
#120Systems and Methods for Control of Refractive Index and Optical Properties in Living Biological Cells
#121ENGINEERED BIFIDOBACTERIUM STRAINS COMPRISING A TRANSGENE
#122METHODS FOR SCREENING VARIANT OF TARGET GENE
#123Inducible CRISPR system expression and applications thereof
#124METHOD FOR GENERATING A MARKER IN A BIOLOGICAL SAMPLE
#125DUAL-CONTROLLED DRUG AND PHOTOACTIVATABLE SYSTEM FOR SPATIOTEMPORAL CONTROL OF CELL THERAPY
#126AUTO-INDUCTION REGULATORY SYSTEM BASED ON QUORUM SENSING AND APPLICATION THEREOF
#127ENGINEERED CELLS FOR CONTROLLED PRODUCTION
#128METHODS AND SYSTEM OF MANAGING RESOURCE COMPETITION IN SYNTHETIC GENE CIRCUITS
#129VECTORS FOR USE IN AN INDUCIBLE COEXPRESSION SYSTEM
#130Method for Transduction of T Cells in the Presence of Malignant Cells
#131COMPOSITIONS AND METHODS FOR MULTIPLEXED QUANTITATIVE ANALYSIS OF CELL LINEAGES
#132Recombinant expression vector for high expression of brazzein in and method for mass-production of brazzein using the same
#133Engineered Bacteria Containing Biosensors for Precision Targeting and Containment
#134FUNCTIONAL NUCLEIC ACID MOLECULES UPREGULATING THE TRANSLATION OF A FRATAXIN MRNA
#135ENUMERATION OF GENETICALLY ENGINEERED MICROORGANISMS BY LIVE CELL COUNTING TECHNIQUES
#136A METHOD FOR RECOMBINANT PROTEIN PRODUCTION
#137GENETICALLY ENGINEERED MICROORGANISMS AND METHODS OF USE
#138CONSTRUCT FOR CONTINUOUS MONITORING OF LIVE CELLS
#139REGULATABLE ADENO-ASSOCIATED VIRUS (AAV) VECTOR
#140GENETIC AMPLIFIED TUMOR HOMING NANOPARTICLES AND COMPOSITIONS AND METHODS THEREOF
#141Mut- methylotrophic yeast
#142Inducible AAV System Comprising Cumate Operator Sequences
#143ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING A MEMBER OF THE B7 FAMILY OF COSTIMULATORY LIGANDS AND ADA
#144Targeted In Vivo Genome Modification
#145COMPOSITIONS AND METHODS FOR TREATING CANCER
#146INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS
#147Instruments, modules, and methods for improved detection of edited sequences in live cells
#148FUSOGENIC LIPID NANOPARTICLES FOR THE TARGET CELL-SPECIFIC PRODUCTION OF RAPAMYCIN INDUCIBLE THERAPEUTIC PROTEINS
#149AAV-based conditional expression system
#150THERAPEUTIC ADENO-ASSOCIATED VIRUS FOR TREATING POMPE DISEASE
#151INDUCIBLE EXPRESSION CASSETTE, AND USES THEREOF
#152Methods and systems for generating complex spatial patterns
#153IMPROVED VECTOR SYSTEMS FOR CAS PROTEIN AND SGRNA DELIVERY, AND USES THEREFOR
#154Pyruvate-responsive biosensor, and construction method and use thereof
#155METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#156TARGETED INTEGRATION OF NUCLEIC ACIDS
#157Hepatocyte based insulin gene therapy for diabetes
#158MATERIALS AND METHODS FOR THE CORRECTION OF RETINITIS PIGMENTOSA
#159Potent and short promoter for expression of heterologous genes
#160PROGRAMMABLE DIFFERENTIATION CONTROL NETWORK
#161GENETICALLY ENGINEERED CELL AND APPLICATION THEREOF
#162GENOME-MODIFIED RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
#163Biosensor Tattoos and Uses Therefor for Biomarker Monitoring
#164Frataxin expression constructs
#165Bacillus subtilis efficiently-induced expression system based on artificial series promoter
#166Novel fungal autoinducible expression system
#167COMPOSITIONS AND METHODS FOR CHIMERIC LIGAND RECEPTOR (CLR)-MEDIATED CONDITIONAL GENE EXPRESSION
#168Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
#169Methods and compositions for production of aromatic and other compounds in yeast
#170Methods And Compositions Comprising A Viral Vector For Expression Of A Transgene And An Effector
#171Methods for screening variant of target gene
#172ENGINEERED IMMUNE CELLS AS DIAGNOSTIC PROBES OF DISEASE
#173TREATMENT OF OCULAR DISEASES WITH HUMAN POST-TRANSLATIONALLY MODIFIED VEGF-TRAP
#174ENGINEERED UBIQUITOUS CHROMATIN OPENING ELEMENTS AND USES THEREOF
#175Methods for screening variant of target gene
#176Production and separation of 3-hydroxypropionic acid
#177ACTIVITY-DEPENDENT EXPRESSION CONSTRUCTS AND METHODS OF USING THE SAME
#178Optimized CLN1 genes and expression cassettes and their use
#179Methods and Compositions for Engineering Synthetic Bioswitches for Remote Control of Biological Activity
#180MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
#181Biosensors for detecting and/or neutralizing bioavailable uranium and related U-sensitive genetic molecular components, gene cassettes, vectors, genetic circuits, compositions, methods and systems
#182VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF
#183Programmable transcription factors and methods
#184Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein
#185Engineered Cellular Pathways for Programmed Autoregulation of Differentiation
#186Nucleic acids and vectors for regulated target gene expression in methanotrophic bacteria
#187CRYSTALLINE DIACYLHYDRAZINE AND THE USE THEREOF
#188Immunization agents and methods of use
#189Microorganisms and methods for producing biologics and introducing biologics to sites
#190NEGATIVE SELECTION AND STRINGENCY MODULATION IN CONTINUOUS EVOLUTION SYSTEMS
#191INDUCIBLE EXPRESSION CASSETTE, AND USES THEREOF
#192Multi-chain eukaryotic display vectors and uses thereof
#193Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
#194USE OF PROKARYOTIC TRANSCRIPTIONAL ACTIVATORS AS METABOLITE BIOSENSORS IN EUKARYOTIC CELLS
#195DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF
#196PRODUCTION OF VIRAL VECTORS
#197Compositions and methods for regulating cell osmolarity
#198DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS
#199Promoter
#200AAV-based conditional expression system
#201Induction of neural progenitor cells, oligodendrocyte progenitor cells, and oligodendrocytes by stem cell differentiation using landmark transcription factors
#202TUMOR IMMUNOTHERAPY
#203Methods and compositions for production of aromatic and other compounds in yeast
#204Vectors Conditionally Expressing Protein
#205Engineered Cells Expressing Multiple Immunomodulators and Uses Thereof
#206Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
#207Potent and short promoter for expression of heterologous genes
#208Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids
#209Compositions and methods for treating cancer
#210Frataxin expression constructs
#211Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
#212Biosensor tattoos and uses therefor for biomarker monitoring
#213Vectors and methods for targeted integration in loci comprising constitutively expressed genes
#214Synthetic transcriptional and epigenetic regulators based on engineered, orthogonal zinc finger proteins
#215Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
#216TSP1 AS A MARKER FOR CANCER
#217Systems, methods and compositions for optical stimulation of target cells
#218METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#219Circular nucleic acid vectors, and methods for making and using the same
#220Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
#221GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING ALPHA-1 ANTITRYPSIN (AAT)
#222Methods and compositions for transducing lymphocytes and regulating the activity thereof
#223Genome-modified recombinant adeno-associated virus vectors
#224Hepatocyte based insulin gene therapy for diabetes
#225Immunization agents and methods of use
#226Transgenic mouse for the assessment of thyroid hormone (TH) action
#227Multi-chain eukaryotic display vectors and uses thereof
#228Engineered Dendritic Cells and Uses for the Treatment of Cancer
#229Extensible recombinase cascades
#230Virus-based expression vectors and uses thereof
#231Methods and compositions for transducing lymphocytes and regulated expansion thereof
#232REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINS
#233Compositions and methods for treatment of muscular dystrophy
#234Production of viral vectors
#235Nucleic acids and vectors for use with methanotrophic bacteria
#236Use of chimeric nucleases to stimulate gene targeting
#237Crystalline diacylhydrazine and the use thereof
#238METHOD FOR SUPPRESSING CELL GROWTH
#239METHODS AND COMPOSITIONS RELATING TO RESTRICTED EXPRESSION LENTIVIRAL VECTORS AND THEIR APPLICATIONS
#240Activity-dependent expression of nucleic acids
#241GENETICALLY MODIFIED MESENCHYMAL STEM CELLS THAT EXPRESS AN EXOGENOUS CYTOTOXIC PROTEIN
#242Synthetic genes and genetic constructs
#243Yeasts modified to use carbon dioxide
#244PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM
#245Brown adipocyte modification
#246Vectors for use in an inducible coexpression system
#247Method of obtaining transformed plant cell
#248DNA vector production system
#249GENERATION OF LAYERED TRANSCRIPTIONAL CIRCUITRY USING CRISPR SYSTEMS
#250METHODS FOR ENHANCING THE DELIVERY OF ACTIVE AGENTS
#251Vectors Conditionally Expressing Protein
#252Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
#253Expression vector
#254Method for optically controlling a neuron with a mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from natromonas pharaonis (NpHR)
#255Materials and methods for the treatment of pathological neovascularization in the eye
#256Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
#257-Prom mediated surface expression of avidin/streptavidin
#258Positive-Selection Cloning and Expression Vector Based on the Toxicity of Killin
#259Devices, systems and methods for optogenetic modulation of action potentials in target cells
#260Multi-chain eukaryotic display vectors and uses thereof
#261Vector construct with human hypoxia inducible factor α gene
#262Designer circuit controlling diet-induced obesity
#263VECTORS FOR USE IN AN INDUCIBLE COEXPRESSION SYSTEM
#264COMPOSITIONS AND METHODS FOR INCREASING PLANT GROWTH AND YIELD
#265Compositions and methods for regulating cell osmolarity
#266RNA silencing in animals as an antiviral defense
#267Translational enhancer-element dependent vector systems
#268Baculoviral DNA elements for the expression of recombinant proteins in a host insect
#269Minicircle DNA vector preparations and methods of making and using the same
#270TRANSGENIC NON-HUMAN ANIMAL AND USES THEREOF
#271Endothelial cell-specific polynucleotides and use thereof
#272OPTICAL REGULATION OF GENE EXPRESSION IN THE RETINA
#273Target molecules for transcriptional control systems
#274Ligand screening and discovery
#275Circular nucleic acid vectors, and methods for making and using the same
#276Conditional vectors and uses thereof
#277Crystalline diacylhydrazine and the use thereof
#278Nucleic acid for treatment or prevention of immunodeficiency virus infection
#279Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
#280Vectors conditionally expressing protein
#281Engineered cellular pathways for programmed autoregulation of differentiation
#282Brown adipocyte modification
#283Production of viral vectors
#284Control of gene expression
#285Hepatocyte based insulin gene therapy for diabetes
#286Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
#287Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR)
#288Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
#289Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#290Steroidal ligands and their use in gene switch modulation
#291Multi-chain eukaryotic display vectors and uses thereof
#292Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
#293Genotoxic testing
#294Synthetic genes and genetic constructs
#295Promoters exhibiting endothelial cell specificity and methods of using same
#296Ligand screening and discovery
#297Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
#298Transgenic fish and uses thereof
#299Engineered dendritic cells and uses for the treatment of cancer
#300FROG/TOAD conditionally silenced vectors for hypoxia gene therapy